Skip to main content
. 2015 Oct 20;128(20):2726–2730. doi: 10.4103/0366-6999.167297

Table 1.

Age distribution of HPIV positive patients, n (%)

Groups n HPIV1 HPIV2 HPIV3 HPIVs
≤6 months 8538 60 (0.70) 4 (0.05) 469 (5.49) 533 (6.24)
~1-year 4077 62 (1.52) 7 (0.17) 352 (8.63) 421 (10.33)
~2 years 3675 60 (1.63) 5 (0.14) 309 (8.41) 374 (10.18)
~3 years 2464 38 (1.54) 3 (0.12) 124 (5.03) 165 (6.70)
~4 years 1980 23 (1.16) 3 (0.15) 62 (3.13) 88 (4.44)
~5 years 1081 6 (0.56) 2 (0.19) 17 (1.57) 25 (2.31)
~6 years 798 3 (0.38) 2 (0.25) 17 (2.13) 22 (2.76)
~7 years 750 4 (0.53) 1 (0.13) 8 (1.07) 13 (1.73)
~8 years 635 2 (0.31) 1 (0.16) 9 (1.42) 12 (1.89)
~9 years 513 1 (0.19) 0 (0) 5 (0.97) 6 (1.17)
~10 years 421 0 (0) 0 (0) 7 (1.66) 7 (1.66)
~11 years 288 0 (0) 0 (0) 1 (0.35) 1 (0.35)
~12 years 230 0 (0) 0 (0) 2 (0.87) 2 (0.87)
>12 years 323 2 (0.62) 0 (0) 6 (1.86) 8 (2.48)

Total 25,773 261 (1.01) 28 (0.11) 1388 (5.39) 1675 (6.50)

HPIV: Human parainfluenza virus.